4KB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Krystal Biotech Inc

Watchlist Manager

Watchlist

Price: 292.4 EUR -2.11%

Market Cap: €8.3B

K	Krystal Biotech Inc F:4KB	US
O	Onto Innovation Inc XMUN:NNM	US
	Copernico SIM SpA MIL:COP	IT
U	UniCredit SpA OTC:UNCFF	IT
E	ENEOS Holdings Inc XMUN:JHJ	JP
A	AeroVironment Inc F:JPX	US
L	Lennar Corp DUS:LNN	US
	Site Centers Corp F:DDR	US
C	CRH PLC F:CRG	IE

Profitability Summary

Krystal Biotech Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

94%

Declining Gross Margin

97% > 95%

Exceptional Operating Margin

45%

Negative 3Y Average Operating Margin

-126%

Operating Margin is Increasing

-1 579% > 45%

Exceptional Net Margin

55%

Sustainable 3Y Average Net Margin

12%

Net Margin is Increasing

-348% > 55%

Exceptional Free Cash Flow Margin

59%

Negative 3Y Average Free Cash Flow Margin

-108%

Free Cash Flow Margin is Increasing

-1 391% > 59%

Positive ROE

20%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

ROIC is Increasing

-68% > 38%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.